Integrity Alliance’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
VCM
N
Integrity Alliance's REGN Position: Q1 2026 in Review
Integrity Alliance reduced its Regeneron Pharmaceuticals (REGN) stake by 2.6% in Q1 2026, selling an estimated $9.95K and leaving 489 shares worth $378K. The position accounts for 0.01% of the portfolio, ranked #518.
Integrity Alliance first reported a position in REGN in Q1 2025 and has held it in 3 quarters since. The position peaked at $579K in Q1 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Integrity Alliance held 489 shares of Regeneron Pharmaceuticals worth $378K as of Q1 2026.
- Integrity Alliance sold 13 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $9.95K.
- Regeneron Pharmaceuticals made up 0.01% of Integrity Alliance's portfolio in Q1 2026, its #518 holding.
- Integrity Alliance first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
- Integrity Alliance's Regeneron Pharmaceuticals position peaked at $579K in Q1 2025.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Integrity Alliance's 13F filing for Q1 2026, filed 11 May 2026.